BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 10795866)

  • 1. Current techniques of hyperthermic isolated limb perfusion for malignant melanoma.
    Tominaga R; Kohno H; Mayumi H; Shiraishi K; Nagae S; Nakayama J; Yasui H
    Surg Today; 2000; 30(4):339-42. PubMed ID: 10795866
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Two cases of metastatic malignant melanoma of the lower limb treated with hyperthermic isolated limb perfusion and concomitant infusion of either carboplatin or beta-interferon.
    Nakayama J; Takeuchi M; Mayumi H; Nagae S; Matsuda K; Yasui H; Takahashi S; Hori Y
    J Dermatol; 1996 Jan; 23(1):6-15. PubMed ID: 8720252
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regional hyperthermic perfusion with cisplatin following surgery for malignant melanoma of the extremities.
    Papa MZ; Klein E; Karni T; Koller M; Davidson B; Azizi E; Ben-Ari G
    Am J Surg; 1996 Apr; 171(4):416-20. PubMed ID: 8604833
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Surgical treatment of malignant melanoma of the limbs combined with thermochemotherapy under extracorporeal circulation].
    Truchetet F; Grosshans E; Kretz JG; Bartier JC; Laplanche G
    Ann Dermatol Venereol; 1988; 115(5):573-85. PubMed ID: 3195954
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hyperthermic isolated limb perfusion with intra-arterial administration of carboplatin and/or interferon-beta for the treatment of malignant melanoma of the leg.
    Nakayama J; Takeuchi M; Mayumi H; Nagae S; Matsuda K; Yasui H; Takahashi S; Hori Y
    J Dermatol; 1994 Nov; 21(11):915-22. PubMed ID: 7852655
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Circuit and protocol for hypoxic hyperthermic isolated limb perfusion to treat malignant melanoma.
    Innet LM; Haripershad V; Van Den Berg J; Cooper L
    Perfusion; 2001 Jul; 16(4):325-30. PubMed ID: 11486853
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hyperthermic isolated regional perfusion of the limb with carboplatin.
    Daryanani D; de Vries EG; Guchelaar HJ; van Weerden TW; Hoekstra HJ
    Eur J Surg Oncol; 2000 Dec; 26(8):792-7. PubMed ID: 11087648
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Systemic effects of hyperthermic isolated lower limb perfusion with carboplatin and interferon-beta.
    Tominaga R; Nakano T; Shibata S; Siraishi K; Nagae S; Nakayama J; Yasui H
    Artif Organs; 2001 Jan; 25(1):36-41. PubMed ID: 11167557
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hyperthermic isolated limb perfusion with tumor necrosis factor alone for melanoma.
    Posner MC; Lienard D; Lejeune FJ; Rosenfelder D; Kirkwood J
    Cancer J Sci Am; 1995; 1(4):274-80. PubMed ID: 9166488
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tumour response after hyperthermic isolated limb perfusion for locally advanced melanoma.
    Paulsen IF; Chakera AH; Drejøe JB; Klyver H; Dahlstrøm K; Oturai PS; Mortensen J; Hesse B; Schmidt G; Drzewiecki K
    Dan Med J; 2014 Jan; 61(1):A4741. PubMed ID: 24393586
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term functional outcome after hyperthermic isolated limb perfusion (HILP).
    Knorr C; Melling N; Goehl J; Drachsler T; Hohenberger W; Meyer T
    Int J Hyperthermia; 2008 Aug; 24(5):409-14. PubMed ID: 18608587
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Isolated limb hyperthermic perfusion chemotherapy for melanoma of the extremities].
    Li J; Wang P; Zhu XJ; Song JG; Song JM
    Zhonghua Zhong Liu Za Zhi; 2012 Dec; 34(12):937-9. PubMed ID: 23336382
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Palliation of regional symptoms of advanced extremity melanoma by isolated limb perfusion with melphalan and high-dose tumor necrosis factor.
    Fraker DL; Alexander HR; Andrich M; Rosenberg SA
    Cancer J Sci Am; 1995; 1(2):122-30. PubMed ID: 9166465
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Safe, compact and portable system for regional chemotherapeutic hyperthermic perfusion procedures.
    Fried SJ; Miller R; Weaver FA; Faddis D
    J Extra Corpor Technol; 1993; 25(1):22-6. PubMed ID: 10148571
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Predictors of outcome after hyperthermic isolated limb perfusion: role of tumor response.
    Aloia TA; Grubbs E; Onaitis M; Mosca PJ; Cheng TY; Seigler H; Tyler DS
    Arch Surg; 2005 Nov; 140(11):1115-20. PubMed ID: 16301451
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Hyperthermic-antiblastic isolation perfusion for advanced melanoma of the limbs. The technic, immediate results and a review of the literature].
    Decian F; Balletto N; Camerini G; Depaoli M; D'Aniello R; Ameri A; Brisighella A; Bonalumi U; Bachi V; Civalleri D
    Minerva Chir; 1990 Oct; 45(19):1227-37. PubMed ID: 2074944
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Isolated limb perfusion: a literature review.
    Schaadt J; Crowley R; Miller D; Kavanah M
    J Extra Corpor Technol; 2002 Jun; 34(2):130-43. PubMed ID: 12139123
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Current status of isolated limb infusion with mild hyperthermia for melanoma.
    Thompson JF; Kam PC
    Int J Hyperthermia; 2008 May; 24(3):219-25. PubMed ID: 18393000
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Regional perfusion of the extremity - experience in 81 patients with malignant melanomas (author's transl)].
    Ghussen F; Groth W; Nagel K
    Z Hautkr; 1981 Jul; 56(14):911-20. PubMed ID: 7269716
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hyperthermic isolation limb perfusion for malignant melanoma: a review.
    Coit DG
    Cancer Invest; 1992; 10(4):277-84. PubMed ID: 1628227
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.